Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06QQH
|
|||
| Former ID |
DIB004782
|
|||
| Drug Name |
T-1210
|
|||
| Indication | Allergic conjunctivitis [ICD-11: 9A60.02; ICD-10: H10.1] | Phase 2 | [1] | |
| Company |
Laboratoires Thea
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01344083) Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis. U.S. National Institutesof Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.